DGAP-News: AMSilk raises EUR 29M to accelerate commercialization of its high-performance bio-based silk polymers vom 11.05.2021, 10:22 Uhr Bild: pixabay.com AMSilk raises EUR 29M to accelerate commercialization of its high-performance bio-based silk polymers 11.05.2021 / 10:22 - PRESS RELEASE - silk polymers - AMSilk to accelerate industrial scale-up and expand commercial operations into new markets Munich, May 11, 2021 - AMSilk GmbH ("AMSilk"), the world's first industrial supplier of synthetic silk biopolymers, today announces the successful closing of a EUR 29 million Series C fundraise. The financing was led by Novo Growth, the growth equity arm of Novo Holdings, with participation from new investors Cargill and E.R. Capital Holdings as well as existing investors MIG Verwaltungs AG and ATHOS KG.